Compare VTYX & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTYX | BW |
|---|---|---|
| Founded | 2018 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Building Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.9M | 919.9M |
| IPO Year | 2021 | N/A |
| Metric | VTYX | BW |
|---|---|---|
| Price | $13.99 | $14.69 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $13.50 | $7.00 |
| AVG Volume (30 Days) | 3.4M | ★ 3.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.59 |
| Revenue Next Year | N/A | $14.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $0.22 |
| 52 Week High | $15.34 | $14.76 |
| Indicator | VTYX | BW |
|---|---|---|
| Relative Strength Index (RSI) | 72.58 | 76.67 |
| Support Level | $13.89 | $8.03 |
| Resistance Level | $14.07 | N/A |
| Average True Range (ATR) | 0.03 | 0.98 |
| MACD | -0.11 | 0.55 |
| Stochastic Oscillator | 88.89 | 96.73 |
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.